Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy
Nebout, M.
Acta Leprologica 1(3): 151-158
1983
ISSN/ISBN: 0001-5938 PMID: 6359803 Document Number: 216567
Document emailed within 1 workday
Related Documents
Zhang, M.; Han, X.-X.; Cui, W.-G.; Jia, M.-H.; Meng, X.-D.; Xing, A.-H.; Wu, Y.-H.; Yang, Y.-Y.; Lu, C.-M.; Hu, Q.-H.; Dai, D.; Zhang, Z.-N.; Shang, H. 2008: The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation Japanese Journal of Infectious Diseases 61(5): 361-365Miron, L. 1995: The current therapeutic strategy in testicular cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 99(3-4): 29-39
Gershon, W. 1974: An approach to urban leprosy control. The Greater Madras Leprosy Treatment and Health Education Scheme (Greamaltes) sponsored by the German Leprosy Relief Association Leprosy Review 45(3): 211-217
Gershon, W. 1974: An approach to urban leprosy control. The Greater Madras Leprosy Treatment and Health Education Scheme (Greamaltes) sponsored by the German Leprosy Relief Association Leprosy Review 45(3): 211-217
2006: WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010 Indian Journal of Leprosy 78(1): 33-47
Bégué, P. 1994: Therapeutic strategy for sore throat: current role for targetted antibiotic therapy Allergie et Immunologie 26(9): 341-344
Xu, J.; Cao, H. 2013: Molecular mechanism and therapeutic strategy for resistance to tyrosine kinase inhibitors in targeted treatment of gastrointestinal stromal tumors Zhonghua Wei Chang Wai Ke Za Zhi 16(3): 288-291
Ravasi, G.; Jack, N.; Alonso Gonzalez, Mónica.; Sued, O.; Pérez-Rosales, Mía.Dolores.; Gomez, B.; Vila, M.; Riego, A.del.; Ghidinelli, M. 2011: Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean Revista Panamericana de Salud Publica 30(6): 657-662
DeLateur, B.J.; Hinderer, S.R. 1990: Physiatric therapeutics. 2. Therapeutic heat and cold, electrotherapy, and therapeutic exercise Archives of Physical Medicine and Rehabilitation 71(4-S): S260-S263
Nair, N.G.; Radhakrishna, S.; Christian, M.; Ramakrishnan, R.; Gopi, P.G. 1985: A 20-year study of the Leprosy Control Programme at the Hemerijckx Leprosy Centre in Polambakkam in South India Indian Journal of Leprosy 57(3): 562-574
Bjune, G.; Closs, O.; Barnetson, R.S. 1983: Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control Clinical and Experimental Immunology 54(2): 289-297
Waters, M.F. 1986: Concepts behind the development of multiple drug therapy regimens in leprosy Ethiopian Medical Journal 24(Suppl 1): 61-67
Zúñiga, J.; Vargas-Alarcón, G.; Salgado, N.; Flores, C.; Martínez-Tripp, S.; Miranda, A.; Balbuena, A.; Osnaya, N.; Juárez, F.; Granados, J.; Reyes-Terán, G. 2000: Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. a review Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(3): 284-295
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Scheen, A.J. 2000: Current therapeutics 2000 Revue Medicale de Liege 55(9): 852-861
Leynadier, F.; Perrault, M. 1975: Anti-inflammatory agents in current therapeutics La Revue du Praticien 25(5): 365-373
López Cuéllar, J. 1999: Glycoprotein IIb/IIIa blockers. their usefulness in current cardiovascular therapeutics Archivos del Instituto de Cardiologia de Mexico 69(3): 272-281
Lipman, A.G. 1989: Current information on the use of immunobiologics: comments of the ASHP Commission on Therapeutics Clinical Pharmacy 8(12): 850-851
Apley, M.D.; Brown, S.A.; Fedorka-Cray, P.J.; Ferenc, S.; House, J.K.; Riviere, J.E.; Rice, L.B.; Thornsberry, C.; Waddell, J. 1998: Role of veterinary therapeutics in bacterial resistance development: animal and public health perspectives Journal of the American Veterinary Medical Association 212(8): 1209-1213